Hyperbaric oxygen in the treatment of calciphylaxis: A case series and literature review

Nephrology

Volumn 20, Issue 7, 2015, Pages 444-450

  An, Jennifer ^a   Devaney, Bridget ^a   Ooi, Khai Yang ^a   Ford, Sharon ^a   Frawley, Geoff ^a   Menahem, Solomon ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

calciphylaxis; calcium phosphate product; end stage kidney disease; hyperbaric oxygen; hyperparathyroidism

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; PARATHYROID HORMONE; PHOSPHATE; SODIUM THIOSULFATE; WARFARIN;

ADULT; AGE; ANXIETY; BAROTRAUMA; CALCINOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC PATIENT; DIALYSIS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; GENDER; HUMAN; HYPERBARIC OXYGEN; MALE; MORTALITY; MYOPIA; NAUSEA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT WITHDRAWAL; WOUND HEALING; CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; COMPLICATION; HYPERBARIC OXYGEN THERAPY; MIDDLE AGED; SURVIVAL RATE;

CALCIPHYLAXIS; FEMALE; HUMANS; HYPERBARIC OXYGENATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; WOUND HEALING;

EID: 84930749746     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12433     Document Type: Conference Paper

References (33)

1. Angelis M, Wong LL, Myers SA, Wong LM,. Calciphylaxis in patients on hemodialysis: A prevalence study. Surgery 1997; 122: 1083-1089, discussion 1089-90.
2. Fine A, Zacharias J,. Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int. 2002; 61: 2210-2217.
3. Goel SK, Bellovich K, McCullough PA,. Treatment of severe metastatic calcification and calciphylaxis in dialysis patients. Int. J. Nephrol. 2011; 2011: 701603.
4. Mazhar AR, Johnson RJ, Gillen D, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int. 2001; 60: 324-332.
5. Guldbakke KK, Khachemoune A,. Calciphylaxis. Int. J. Dermatol. 2007; 46: 231-238.
6. Wilmer WA, Magro CM,. Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin. Dial. 2002; 15: 172-186.
7. Rogers NM, Coates PT,. Calcific uraemic arteriolopathy: An update. Curr. Opin. Nephrol. Hypertens. 2008; 17: 629-634.
8. Brandenburg VM, Cozzolino M, Ketteler M,. Calciphylaxis: A still unmet challenge. J. Nephrol. 2011; 24: 142-148.
9. Kerr DN,. Hypercalcemia and metastatic calcification. Cardiovasc. Res. 1997; 36: 293-297.
10. Budisavljevic MN, Cheek D, Ploth DW,. Calciphylaxis in chronic renal failure. J. Am. Soc. Nephrol. 1996; 7: 978-982.
11. Ross EA,. Evolution of treatment strategies for calciphylaxis. Am. J. Nephrol. 2011; 34: 460-467.
12. Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr,. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin. J. Am. Soc. Nephrol. 2013; 8: 1162-1170.
13. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR,. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin. J. Am. Soc. Nephrol. 2006; 1: 1161-1166.
14. Cicone JS, Petronis JB, Embert CD, Spector DA,. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am. J. Kidney Dis. 2004; 43: 1104-1108.
15. Podymow T, Wherrett C, Burns KD,. Hyperbaric oxygen in the treatment of calciphylaxis: A case series. Nephrol. Dial. Transplant. 2001; 16: 2176-2180.
16. Tibbles PM, Edelsberg JS,. Hyperbaric-oxygen therapy. N. Engl. J. Med. 1996; 334: 1642-1648.
17. Gallagher KA, Goldstein LJ, Thom SR, Velazquez OC,. Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing. Vascular 2006; 14: 328-337.
18. Hafner J, Keusch G, Wahl C, et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): A complication of chronic renal failure and benefit from parathyroidectomy. J. Am. Acad. Dermatol. 1995; 33: 954-962.
19. Lal G, Nowell AG, Liao J, Sugg SL, Weigel RJ, Howe JR,. Determinants of survival in patients with calciphylaxis: A multivariate analysis. Surgery 2009; 146: 1028-1034.
20. Basile C,. Hyperbaric oxygen therapy in the treatment of calciphylaxis? Yes, more than hope. Kidney Int. 2002; 62: 2300. author reply 2300.
21. Dwyer KM, Francis DM, Hill PA, Murphy BF,. Calcific uraemic arteriolopathy: Local treatment and hyperbaric oxygen therapy. Nephrol. Dial. Transplant. 2002; 17: 1148-1149.
22. Edsell M, Bailey M, Joe K, Millar I,. Hyperbaric oxygen therapy in the treatment of skin ulcers due to calcific uraemic arteriolopathy: Experience from an Australian hyperbaric unit. Diving Hyperb. Med. 2008; 38: 139-144.
23. Rogers NM, Chang SH, Teubner D, Coates PT,. Hyperbaric oxygen as effective adjuvant therapy in the treatment of distal calcific uraemic arteriolopathy. Nephrol. Dial. Transplant. 2008; 4: 244-249.
24. Arenas MD, Gil MT, Gutierrez MD, et al. Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy. Clin. Nephrol. 2008; 70: 261-264.
25. Alikadic N, Kovac D, Krasna M, et al. Review of calciphylaxis and treatment of a severe case after kidney transplantation with iloprost in combination with hyperbaric oxygen and cultured autologous fibrin-based skin substitutes. Clin. Transplant. 2009; 23: 968-974.
26. Baldwin C, Farah M, Leung M, et al. Multi-intervention management of calciphylaxis: A report of 7 cases. Am. J. Kidney Dis. 2011; 58: 988-991.
27. New N, Mohandas J, John GT, et al. Calcific uremic arteriolopathy in peritoneal dialysis populations. Int. J. Nephrol. 2011; 2011: 982854.
28. Malabu UH, Manickam V, Kan G, Doherty SL, Sangla KS,. Calcific uremic arteriolopathy on multimodal combination therapy: Still unmet goal. Int. J. Nephrol. 2012; 2012: 390768.
29. Savoia F, Gaddoni G, Patrizi A, et al. Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: Report of 4 cases. G. Ital. Dermatol. Venereol. 2013; 148: 531-536.
30. Agarwal MM, Singh SK, Mandal AK,. Penile gangrene in diabetes mellitus with renal failure: A poor prognostic sign of systemic vascular calciphylaxis. Indian J. Urol. 2007; 23: 208-210.
31. Liu R, Li L, Yang M, Boden G, Yang G,. Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin. Proc. 2013; 88: 166-175.
32. Banham ND,. Oxygen toxicity seizures: 20 years' experience from a single hyperbaric unit. Diving Hyperb. Med. 2011; 41: 202-210.
33. Rogers NM, Coates PT,. Calcific uremic arteriolopathy-The argument for hyperbaric oxygen and sodium thiosulfate. Semin. Dial. 2010; 23: 38-42.